Management of Uveitic Glaucoma in Children with Blau Syndrome
Article Sidebar
-
uveitic glaucoma, Blau syndrome, pediatric glaucoma, trabeculectomy
Abstract
Introduction: Glaucoma in children is a condition that potentially cause blindness. Management of uveitic glaucoma is challenging because of the many mechanisms involved in its pathogenesis
Purpose: To report clinical characteristic and management of uveitic glaucoma in children with Blau Syndrome.
Methods: A 13 years old boy came to the hospital with chief complain blurred vision in both eyes. The patient was diagnosed as Blau Syndrome one year ago. He had history of trabeculectomy on his left eye. Scalling skin and swollen joints was found on physical examination. Visual acuity was hand movement in both eyes, intraocular pressure was 34 (right) and 40 (left). Gonioscopy of the right eye was schwabe line in superior and peripheral anterior synechia in three quadrants. At the left eye, there was scleral spur in all quadrant. At the anterior segment of right eye, there was band keratopathy, posterior synechia 360 o , peripheral anterior synechia, and cataract. While at the left eye, there was bleb, band keratopathy, posterior synechia, peripheral iridotomy, and cataract. Trabeculectomy, 5 fluorouracil, synechiolysis, iris retractor, and membranectomy was performed for the right eye.
Conclusion: Uveitic glaucoma in children poses a significant risk of blindness and needs an aggressive treatment to control intraocular pressure and amblyopia therapy to preserve vision.
Full text article
References
Kaur S, Kaushik S, Pandav SS. Pediatric Uveitic Glaucoma. J Current Glau Prac, 2013;7(3): 115-7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741147/
Seth NG, Yangzes S, Thattaruthody F, Singh R, Bansal R, et al. Glaucoma Secondary to Uveitis in Children in a Tertiary Care Referral Center. Ocular Immunology & In?ammation, 2019; 27(3): 456-64 https://pubmed.ncbi.nlm.nih.gov/29394120/
Sharon Y, Friling R, Luski M, Campoverde BQ, Amer R, Kramer M. Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression. Ocular Immunology & In?ammation, 2017; 25(6): 740-7 https://pubmed.ncbi.nlm.nih.gov/27937076/
Negrete FJM, Montañés JM, Martínez PH, Rebolleda G. Current Approach in the Diagnosis and Management of Uveitic Glaucoma. Hindawi, 2015: 1-13 https://www.hindawi.com/journals/bmri/2015/742792/
Carren E, Guly CM, Chilov M, Hinchcli?e A, Arostegui JI, et al. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). Acta Ophtalmologica, 2015; 93: 253-7 https://pubmed.ncbi.nlm.nih.gov/25209167/
Sarens IL, Casteels I, Anton J, Meunier BB, Brissaud P, et al. Blau syndrome-Associated Uveitis: Preliminary Results from an International Prospective Interventional Case Series. American Journal of Ophthalmology, 2018; 187: 158-66 https://pubmed.ncbi.nlm.nih.gov/28887115/
Samant M, Medsinge A, Nischal KK. Pediatric Glaucoma: Pharmacotherapeutic Options. Pediatr Drugs, 2016: 1-11 https://link.springer.com/article/10.1007/s40272-016-0174-4
Carreño E, Villarón S, Portero A, Herreras JM, Maquet JA, Calonge M. Surgical outcomes of uveitic glaucoma. J Ophthal Inflamm Infect. 2011; 1:43–53 https://link.springer.com/article/10.1007/s12348-010-0012-8
Almobarak FA, Alharbi AH, Morales J, Aljadaan I. The in?uence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma. Int Ophthlamol, 2018; 38(6): 2371-9 https://pubmed.ncbi.nlm.nih.gov/29032434/
Nishizawa A, Inoue T, Ohira S, Takahashi E, Saruwatari J, Iwao K, Tanihara H. The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma. Plos One, 2016; 11(3): 1-11 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151947
Shuba L and Kwon YH. Glaucoma: Uveitic Glaucoma. In: Glaconi JA, Law SK, Mahdavi KN, Coleman AL, Caprioli, editors. Pearls of Glaucoma Management. Second Edition.Berlin: Springer; 2016: 447
Authors
Copyright (c) 2022 Ivone Caroline, Elsa Gustianty, Andika Prahasta, R. Maula Rifada
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
